Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults

被引:218
作者
Chen, Chien-Hua
Huang, Min-Ho
Yang, Jee-Chun
Nien, Chiu-Kue
Yang, Chi-Chieh
Yeh, Yung-Hsiang
Yueh, Sen-Kou
机构
[1] Show Chwan Mem Hosp, Ctr Digest Dis, Changhua 500, Taiwan
[2] Show Chwan Mem Hosp, Dept Med Res, Changhua 500, Taiwan
关键词
nonalcoholic fatty liver disease; ultrasonography; obesity;
D O I
10.1097/00004836-200609000-00016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The prevalence of nonalcoholic fatty liver disease (NAFLD) is rarely reported in Taiwan. Goals: To determine the prevalence and risk factors of NAFLD in an adult population of Taiwan. Study: The cross-sectional community study examined 3245 adults in a rural village of Taiwan. The diagnostic criteria for NAFLD included no excessive alcohol intake, no chronic viral hepatitis, no known etiologies of liver disease, and ultrasonography consistent with fatty liver. Results: The prevalence of NAFLD was 11.5% (372/3245). The risk factors for NAFLD in the general population were male sex [odds ratio (OR), 1.44; 95% confidence interval (CI), 1.09-1.90], elevated alanine aminotransferase (ALT) (OR, 5.66; 95% CI, 3.99-8.01), obesity (OR, 7.21; 95% CI, 5.29-9.84), fasting plasma glucose >= 126 mg/dL (OR, 2.08; 95% CI, 1.41-3.05), total cholesterol >= 240mg/dL (OR, 1.50; 95% CI, 1.06-2.13), triglyceride >= 150mg/dL (OR, 1.76; 95% CI, 1.32-2.35), and hyperuricemia (OR, 1.53; 95% CI, 1.16-2.01). Age >= 65 years was inversely related to NAFLD (OR, 0.53; 95% CI, 0.36-0.77). The only NAFLD risk factors among nonobese subjects were age between 40 and 64 years (OR, 2.35; 95% CI, 1.34-4.11, P = 0.003), elevated ALT (OR, 15.45; 95% CI, 8.21-29.09, P < 0.001), and triglyceride 150 mg/dL (OR, 2.48; 95% CI, 1.42-4.32, P = 0.001). In subjects with NAFLD, the prevalence of elevated ALT in the presence of each metabolic risk factor, such as obesity, fasting plasma glucose >= 126mg/dL, total cholesterol >= 240 mg/dL, triglyceride >= 150 mg/dL, and hyperuricemia, did not differ from that of subjects with normal ALT levels. Conclusions: NAFLD is closely associated with elevated ALT, obesity, diabetes mellitus, hypercholesterolemia, hypertriglyceridemia, and hyperuricemia. Among the metabolic disorders,
引用
收藏
页码:745 / 752
页数:8
相关论文
共 47 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases [J].
Angelico, F ;
Del Ben, M ;
Conti, R ;
Francioso, S ;
Feole, K ;
Maccioni, D ;
Antonini, TM ;
Alessandri, C .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (05) :588-594
[3]   Fatty infiltration of liver in hyperlipidemic patients [J].
Assy, N ;
Kaita, K ;
Mymin, D ;
Levy, C ;
Rosser, B ;
Minuk, G .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) :1929-1934
[4]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[5]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52
[6]   The epidemiology of fatty liver [J].
Bellentani, S ;
Bedogni, G ;
Miglioli, L ;
Tiribelli, C .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (11) :1087-1093
[7]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[8]  
CALDWELL SH, 2001, AM J GASTROENTEROL, V358, P893
[9]   Non-alcoholic steatohepatitis in the Asia-Pacific region: Future shock? [J].
Chitturi, S ;
Farrell, GC ;
George, J .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (04) :368-374
[10]   Clinical aspects of fatty liver disease [J].
Choudhury, J ;
Sanyal, AJ .
SEMINARS IN LIVER DISEASE, 2004, 24 (04) :349-362